Search

A new study shows that the use of a wearable cardioverter defibrillator (WCD) is safe and effective in treating ventricular arrhythmias for pediatric patients who are at risk for sudden cardiac death (SCD). The study represents the largest pediatric patient population to date when evaluating the WCD as a therapy option. The findings of the study were presented today at Heart Rhythm 2017, the Heart Rhythm’s 38th Annual Scientific Sessions.

A new study shows that the Apple Watch's heart rate sensor, when paired with an artificial intelligence-based algorithm, can detect a serious and often symptomless heart arrhythmia, atrial fibrillation (AF). The new research uses a deep neural network based on photoplethysmographic (PPG) sensors commonly found in smart watches. The results of this study were presented today at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.

Heart Rhythm 2016, the Heart Rhythm Society’s (HRS) 37th Annual Scientific Sessions and this year’s leading conference on cardiac arrhythmias, commences at the Moscone Center. The meeting focuses on the importance of collaboration to propel the field of cardiac pacing and electrophysiology (EP) forward. HRS is the only organization that brings together the world’s leading clinicians, scientists and allied health professionals to help end death and suffering from heart rhythm disorders.

The Heart Rhythm Society (HRS) encourages and supports the efforts of early career electrophysiologists and other heart rhythm professionals to participate in the Society’s activities. To that end, the Heart Rhythm Travel Scholarships support participation in the Annual Scientific Sessions with a complimentary registration to Heart Rhythm, up to $1,500 in reimbursement of travel costs paid after the Annual Scientific Sessions, and award presentation at the Heart Rhythm Society VIP Reception.